Antibodies, Antiphospholipid

SAN DIEGO — Patients with systemic lupus erythematosus who are positive for antiphospholipid antibodies have a greater risk for future atherosclerotic cardiovascular disease, according to data presented at ACR Convergence 2023.

A significant proportion of patients with COVID-19 — up to 52% by one metric — are at least transiently positive for potentially pathogenic antiphospholipid autoantibodies, according to a speaker at ACR Convergence.